The PennZone

  • Home
  • Business
  • Health
  • Education
  • Technology
  • Non-profit
  • Entertainment
  • Travel
  • Financial

Suvoda Introduces Extensible Software Platform Bringing Proven Tech Innovation to Clinical Trial Management Deutschland - Deutsch España - español France - Français USA - English
The PennZone/10219635

Trending...
  • The Tide Project Opens at Biennale Architettura 2025 in Venice Amplifying Youth Voices
  • ImagineX, in Collaboration with Qualys, Launches New mROC Services to Transform Enterprise Cyber Risk Management
  • New National Nonprofit Launches to Capture Firsthand Accounts of Adoption Stories
Platform reduces friction across the eConsent, IRT, and eCOA user experience for sponsors, CROs, sites and patients.

PHILADELPHIA, Feb. 6, 2023 /PRNewswire/ -- Suvoda LLC, a global clinical trial technology company that specializes in complex studies in therapeutic areas like oncology, central nervous system (CNS), and rare disease, today unveiled a purpose-built software platform designed specifically to provide drug trial sponsors and sites a seamless way to manage complex, mission-critical, and time-sensitive moments on the patient journey. Click to tweet.

Drawing on more than a decade of expertise following the launch of its innovative IRT solution, and having supported more than 1,000 trials across 80 countries, Suvoda introduces a low-code/no-code platform to the eClinical market unifying its eConsent, IRT, and eCOA solutions. Designed to address real challenges facing clinical trials, the Suvoda Platform minimizes friction across the user experience, while reducing and simplifying integrations, and strengthening data governance, so studies can be implemented more efficiently and with less risk of downtime.

"Clinical trials are increasingly complex, expensive, and fraught with challenges that are affecting trial execution – mid-study changes, data silos, trial delays, and more," said Jagath Wanninayake, CEO of Suvoda. "To meet these challenges, our team organically built a platform upon which we are delivering the next generation of clinical trial applications designed to handle complexity with ease, and reduce overall risk throughout trials. Our goal is always for sponsors and site users to spend less time with technology and more time on what is most important to them…uncovering scientific breakthroughs and focusing on the patients we all ultimately serve."

The Suvoda Platform enables Suvoda's IRT, eConsent, and eCOA solutions to work seamlessly together and harmoniously with other applications, to be easily tailored to meet the needs of each protocol, and to be upgradable to benefit from continuous enhancements. The Suvoda Platform provides a number of benefits, including:

More on The PennZone
  • SlotCycle Joins Association of Gaming Equipment Manufacturers (AGEM) to Advance Sustainable Gaming Solutions
  • Jerry Launches Revamped Website to Help Drivers Make Smarter Insurance and Auto Decisions
  • RWA Infra Development L.L.C. announces the $RWAID token. "$RWAID tokenizing infrastructure for the masses."
  • Adventure is in the Journey with the New Lumber Heritage Trail Interactive Mobile App
  • Mental Health Awareness Month—Tennessee Enacts Psychotropic Testing Law

Enhanced user experience and reduced workload. The new platform enables single sign-on and provides a consistent interface across Suvoda's eConsent, IRT, and eCOA solutions, with smooth user workflows that allow clinicians to move seamlessly from one task to the next. This reduces workload and training so sites can focus more of their time on research and patients.

Rapid design and deployment of complex trials. The platform's low-code/no-code technology streamlines study start-up and mid-study changes, even for the most complex trials, while advanced design tools make customizations more practical and sponsor standards easier to implement. A harmonized deployment process across three solutions saves study teams time and effort.

Improved data workflow and reduced integrations. Suvoda's unified platform enables all patient and site data across eConsent, IRT, and eCOA to be centrally collected, managed, analyzed, and stored. This is expected to result in better data governance for sponsors, provide sites access to real-time information, and deliver a more robust eClinical ecosystem. In addition, customers benefit from three already-integrated solutions–eConsent, IRT and eCOA–while the platform's comprehensive API surface simplifies other necessary integrations with third-party solutions and sponsor systems.

Future-proofed eClinical programs. Users of the platform will always have the latest trial technology with Suvoda because upgrades can be made throughout the life of the trial without losing customizations. In addition, with release opt-in, customers can choose which updates to accept, giving them control of their internal validation, acceptance, and training processes. Finally, Suvoda makes implementing enterprise standards future-proof by allowing sponsors to upgrade while maintaining their proprietary processes and standards across all products built on the Suvoda Platform.

"Whether it's sponsors, CROs, site teams, or patients, users expect a seamless trial experience digitally and in-person, so we've designed the new platform to deliver that," said Andrew McVeigh, chief architect at Suvoda. "Suvoda offers a powerful trial management platform that feels like a consumer app because we've put the user at the center of our design. Our robust back-end and intuitive design puts greater control into our customers' hands and delivers the power to manage trials of any level of complexity."

More on The PennZone
  • Be Prepared for the Qualitative and Quantitative Effects of Tariffs: How Businesses Can Navigate Potential Disruption in Finances and Production
  • Bold Beauty Project UCLA Edition Photography Exhibition on May 18
  • Genuine Hospitality, LLC Selected to Operate Claridge House Chicago Gold Coast
  • Lamar Odom Issues Public Challenge to X Platform Over Censorship of His Anti-Addiction Crypto Campaign
  • PBK Miner completes $80 million Series B financing to support AI cloud mining and increase user investment return by 25%

Click here for more information on the Suvoda Platform.

About Suvoda

Suvoda is a global clinical trial technology company specializing in complex, life-sustaining studies in therapeutic areas like oncology, central nervous system (CNS), and rare disease. Founded in 2013 by experts in eClinical technologies, Suvoda empowers clinical trial professionals to manage the most urgent moments in the most urgent trials through advanced software solutions delivered on a single platform. Headquartered outside Philadelphia, Suvoda also maintains offices in Portland, OR, Barcelona, Spain, Bucharest, Romania, and Tokyo, Japan. The company consistently boasts a Net Promoter Score (NPS) of close to 70, far exceeding the technology industry average of 50, and has been selected by trial sponsors and CROs to support more than 1,000 trials across 80 countries. To learn more, visit suvoda.com. Follow Suvoda on Twitter and LinkedIn.

For information contact:

Mara Conklin, (847) 340-6823
[email protected]

Kathy Zoeller, (312) 485-2422
[email protected]

Logo - https://mma.prnewswire.com/media/1759317/Suvoda_Logo.jpg

SOURCE Suvoda LLC
Filed Under: Business

Show All News | Report Violation

0 Comments
1000 characters max.

Latest on The PennZone
  • Adster Techologies awarded US Patent for breakthrough innovation in reducing latency in Ad Serving
  • Robert Fabbio Inducted into the Austin Technology Council Hall of Fame
  • Cybersecurity is Protecting Your Personal Information and Your Portfolio
  • L2 Aviation Celebrates Grand Opening of New Facility at Cincinnati/Northern Kentucky International Airport (CVG)
  • Managing Summer Staffing Surges with Confidence: Why Name Badges Are a Must for Seasonal Success
  • Visa Named Title Sponsor of Ascending Athletes' Business Owners Summits for NFL Entrepreneurs
  • The Paris Court of International Arbitration Elects Dr. John J. Maalouf as its New President
  • $56.7 Million Announced in Q1 2025 with Revenue Growth and Progress Toward NASDAQ Uplisting for AI Marketing Company: IQSTEL, Inc. Stock Symbol: IQSTD
  • SAVVY MINING raised $500 million and launched BTC.XRP.DOGE cloud mining, increasing investors' returns by 30%
  • New National Nonprofit Launches to Capture Firsthand Accounts of Adoption Stories
  • The Tide Project Opens at Biennale Architettura 2025 in Venice Amplifying Youth Voices
  • Wall Street analysts say BTC.XRP.DOGE cloud mining company SIX MINING is expected to achieve a 5-fold increase, allowing users to easily mine BTC
  • Gen X Takes The Reins: New Book Guides Caregivers Juggling Parents, Kids, And Grandkids With Humor And Heart
  • Fray Fitness Launches Memorial Day Sale and Veteran Organization Giveaway
  • Nurse leader Julie Nyhus has been named editorial director of American Nurse Journal
  • ABM for Good™ Launches First Project with Build Change
  • Braces for Teenagers in Allentown Offered by Exeter Smiles
  • Roots for Boots to Host "Bike Day Bash" Featuring Trike Presentation to Local Veteran
  • JOSHWAY Cuts Ribbon on New Brick-and-Mortar Location
  • ImagineX, in Collaboration with Qualys, Launches New mROC Services to Transform Enterprise Cyber Risk Management

Popular on PennZone

  • Gas Wolf® Officially Becomes a Registered Trademark - 1389
  • Jed the Fish, The Rapscallion of Los Angeles KROQ's Airwaves and Provocateur, Has Signed Off at 69 - 129
  • The World's No.1 Superstar Champions the NO FAKES Act – Secures Global Identity and Cultural Legacy - 102
  • Goosechase Rolls Out Unlockable Missions, Its Most Anticipated Feature Yet
  • Portland Hosts Mensa's 2025 Mind Games®
  • PebblePad Welcomes Justin Reilly as New CEO to Drive Innovation and Growth
  • HR Tech Awards Program Celebrates 6th Year: Showcases Top Hiring, Talent, and HR Technologies
  • Museum Hack Presents Hacked Gala: A Rebellious Night of Art, Fashion, and Change at the Met
  • ServiceAgent.ai Brings 24/7 AI Call Answering to America's Home Services
  • Damian Redd's "Caught in a Fantasy" Surpasses 100,000 Views on VEVO/YouTube Following Album Reissue

Similar on PennZone

  • Mother's Day Wake-Up Call for Maternal Health: New Initiative Demands Better Postpartum Support
  • Southbox Entertainment, FinTech Pioneer & Entrepreneur Jon Gosier Join Psychological Thriller The Dutchman as Financing Partner
  • SlotCycle Joins Association of Gaming Equipment Manufacturers (AGEM) to Advance Sustainable Gaming Solutions
  • Jerry Launches Revamped Website to Help Drivers Make Smarter Insurance and Auto Decisions
  • RWA Infra Development L.L.C. announces the $RWAID token. "$RWAID tokenizing infrastructure for the masses."
  • Be Prepared for the Qualitative and Quantitative Effects of Tariffs: How Businesses Can Navigate Potential Disruption in Finances and Production
  • Genuine Hospitality, LLC Selected to Operate Claridge House Chicago Gold Coast
  • PBK Miner completes $80 million Series B financing to support AI cloud mining and increase user investment return by 25%
  • Asset-Backed Green Crypto: Fueling the Trillion-Dollar Revolution
  • QVC Honors Elton John with Inaugural Icon Award
Copyright © The PennZone | Theme: OMag by LilyTurf Themes
  • Contribute
  • Privacy Policy
  • Terms of Service
  • Contact Us